Management of Borderline Resectable Pancreatic Cancer

被引:49
作者
Katz, Matthew H. G. [1 ]
Crane, Christopher H. [2 ]
Varadhachary, Gauri [3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Med Oncol, Houston, TX 77030 USA
关键词
GEMCITABINE-BASED CHEMORADIATION; EXPERT CONSENSUS STATEMENT; PREOPERATIVE GEMCITABINE; RADIATION-THERAPY; MULTIINSTITUTIONAL PHASE-2; NEOADJUVANT GEMCITABINE; CONTROLLED-TRIAL; DOSE-ESCALATION; ADENOCARCINOMA; CHEMOTHERAPY;
D O I
10.1016/j.semradonc.2013.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Borderline resectable pancreatic cancers are those that, although technically resectable, are at high risk for margin-positive resection following surgery de novo. Generally, such cancers are characterized by localized primary tumors that involve the mesenteric vasculature to a limited degree and that may require venous or hepatic arterial resection at pancreatectomy. In this article, we review diagnosis and staging algorithms, pretreatment strategies, and multidisciplinary treatment protocols for patients with this stage of disease. The rationale for and results following treatment with neoadjuvant chemotherapy and chemoradiation and subsequent surgical resection of the primary tumor are described in detail and existing data are reviewed. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 42 条
  • [21] Needle tract implantation of hepatocellular carcinoma and pancreatic carcinoma after ultrasound-guided percutaneous puncture: Clinical and pathologic characteristics and the treatment of needle tract implantation
    Kosugi, C
    Furuse, J
    Ishii, H
    Maru, Y
    Yoshino, M
    Kinoshita, T
    Konishi, M
    Nakagohri, T
    Inoue, K
    Oda, T
    [J]. WORLD JOURNAL OF SURGERY, 2004, 28 (01) : 29 - 32
  • [22] Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally advanced pancreatic adenocarcinoma
    Lee, Jae-Lyun
    Kim, Song Cheol
    Kim, Ji-Hoon
    Lee, Sang Soo
    Kim, Tae-Won
    Park, Do Hyun
    Seo, Dong Wan
    Lee, Sung Koo
    Kim, Myung-Hwan
    Kim, Jong Hoon
    Park, Jin-Hong
    Shin, Sang Hyun
    Han, Duck Jong
    [J]. SURGERY, 2012, 152 (05) : 851 - 862
  • [23] Arterial Resection During Pancreatectomy for Pancreatic Cancer A Systematic Review and Meta-Analysis
    Mollberg, Nathan
    Rahbari, Nuh N.
    Koch, Moritz
    Hartwig, Werner
    Hoeger, Yumiko
    Buechler, Markus W.
    Weitz, Juergen
    [J]. ANNALS OF SURGERY, 2011, 254 (06) : 882 - 893
  • [24] Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial
    Motoi, Fuyuhiko
    Ishida, Kazuyuki
    Fujishima, Fumiyoshi
    Ottomo, Shigeru
    Oikawa, Masaya
    Okada, Takaho
    Shimamura, Hiromune
    Takemura, Shinichi
    Ono, Fuminori
    Akada, Masanori
    Nakagawa, Kei
    Katayose, Yu
    Egawa, Shinichi
    Unno, Michiaki
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (12) : 3794 - 3801
  • [25] Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
    Mukherjee, Somnath
    Hurt, Christopher N.
    Bridgewater, John
    Falk, Stephen
    Cummins, Sebastian
    Wasan, Harpreet
    Crosby, Tom
    Jephcott, Catherine
    Roy, Rajarshi
    Radhakrishna, Ganesh
    McDonald, Alec
    Ray, Ruby
    Joseph, George
    Staffurth, John
    Abrams, Ross A.
    Griffiths, Gareth
    Maughan, Tim
    [J]. LANCET ONCOLOGY, 2013, 14 (04) : 317 - 326
  • [26] Munroe Craig A, 2013, Expert Opin Med Diagn, V7, P25, DOI 10.1517/17530059.2012.711313
  • [27] NCCN, 2012, PANCR AD VERS 2 2012
  • [28] Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial
    Neoptolemos, JP
    Stocken, DD
    Dunn, JA
    Almond, J
    Beger, HG
    Pederzoli, P
    Bassi, C
    Dervenis, C
    Fernandez-Cruz, L
    Lacaine, F
    Buckels, J
    Deakin, M
    Adab, FA
    Sutton, R
    Imrie, C
    Ihse, I
    Tihanyi, T
    Olah, A
    Pedrazzoli, S
    Spooner, D
    Kerr, DJ
    Friess, H
    Büchler, MW
    [J]. ANNALS OF SURGERY, 2001, 234 (06) : 758 - 768
  • [29] Pappas SG, 2013, STAGING CHEST COMPUT
  • [30] Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer
    Pawlik, Timothy M.
    Laheru, Daniel
    Hruban, Ralph H.
    Coleman, JoAnn
    Wolfgang, Christopher L.
    Campbell, Kurt
    Ali, Syed
    Fishman, Elliot K.
    Schulick, Richard D.
    Herman, Joseph M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (08) : 2081 - 2088